Published in Heart on October 01, 2003
No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction. Indian Heart J (2016) 0.79
Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests. Int J Cardiovasc Imaging (2017) 0.78
Thrombus aspiration in acute myocardial infarction: Rationale and indication. World J Cardiol (2014) 0.77
Noninvasive assessment of myocardial damage after acute anterior myocardial infarction: myocardial blush grade in conjunction with analysis of coronary flow pattern. Heart Vessels (2010) 0.75
The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations. J Clin Med Res (2015) 0.75
Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial. Cardiol Ther (2016) 0.75
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr (1990) 25.24
The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med (1985) 7.29
TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation (1996) 4.41
Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation (1992) 3.73
Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation (1998) 3.70
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation (2000) 2.93
Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation (1996) 2.59
Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol (2002) 1.95
Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation (1996) 1.41
Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. Circulation (2000) 1.25
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol (2001) 1.22
Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion. J Am Coll Cardiol (2003) 1.12
Short and long term predictive value of admission wall motion score in acute myocardial infarction. A cross sectional echocardiographic study of 345 patients. Br Heart J (1986) 1.03
Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second-generation echocardiographic contrast agent. Circulation (1997) 1.00
Coronary flow velocity immediately after primary coronary stenting as a predictor of ventricular wall motion recovery in acute myocardial infarction. J Am Coll Cardiol (2000) 0.99
Early temporal changes in coronary flow velocity patterns in patients with acute myocardial infarction demonstrating the "no-reflow" phenomenon. Am J Cardiol (1999) 0.95
Repeated assessment of coronary flow velocity pattern in patients with first acute myocardial infarction. J Am Coll Cardiol (2002) 0.93
Coronary flow reserve may predict myocardial recovery after myocardial infarction in patients with TIMI grade 3 flow. Am Heart J (1998) 0.88
Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation (1991) 3.70
Analysis of the functional role of the Polycomb chromo domain in Drosophila melanogaster. Genes Dev (1992) 3.04
Molecular characterization of the male-specific lethal-3 gene and investigations of the regulation of dosage compensation in Drosophila. Development (1995) 2.16
Fragmentation of massive pulmonary embolism using a pigtail rotation catheter. Chest (1998) 2.12
Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol (1996) 2.09
Evaluation of the SOFA score: a single-center experience of a medical intensive care unit in 303 consecutive patients with predominantly cardiovascular disorders. Sequential Organ Failure Assessment. Intensive Care Med (2000) 1.92
Refinements in stress echocardiographic techniques improve inter-institutional agreement in interpretation of dobutamine stress echocardiograms. Eur Heart J (2002) 1.87
The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart (2001) 1.86
Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol (2001) 1.80
Functional, angiographic and intracoronary Doppler flow characteristics in symptomatic patients with myocardial bridging: effect of short-term intravenous beta-blocker medication. J Am Coll Cardiol (1996) 1.79
Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology (1996) 1.77
The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med (2003) 1.69
The dosage compensation system of Drosophila is co-opted by newly evolved X chromosomes. Nature (1996) 1.68
Disturbed intracoronary hemodynamics in myocardial bridging: early normalization by intracoronary stent placement. Circulation (1997) 1.67
Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.57
Attempt to quantitate relation between cardiac function and infarct size in acute myocardial infarction. Br Heart J (1974) 1.57
Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study. Am J Cardiol (1980) 1.56
Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes. Eur Respir J (2010) 1.55
Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation (1995) 1.54
Non-contrast second harmonic imaging improves interobserver agreement and accuracy of dobutamine stress echocardiography in patients with impaired image quality. Heart (2000) 1.54
M-mode echocardiography overestimates left ventricular mass in patients with normal left ventricular shape: a comparative study using three-dimensional echocardiography. Eur J Echocardiogr (2003) 1.54
Simultaneous transesophageal atrial pacing and transesophageal two-dimensional echocardiography: a new method of stress echocardiography. J Am Coll Cardiol (1990) 1.52
Congenital quadricuspid aortic valve anomaly associated with hypertrophic non-obstructive cardiomyopathy: a case report and review of the literature. Heart (1997) 1.50
Infarct size estimated from serial serum creatine phosphokinase in relation to left ventricular hemodynamics. Circulation (1977) 1.48
Long term angiographic and clinical follow up in patients with stent implantation for symptomatic myocardial bridging. Heart (2000) 1.45
Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa. Hepatology (1998) 1.45
Extent and severity of test positivity during dobutamine stress echocardiography. Influence on the predictive value for coronary artery disease. Eur Heart J (1999) 1.40
[Doppler echocardiography in prosthetic heart valve replacement]. Dtsch Med Wochenschr (1991) 1.38
Gastric tonometry in patients with cardiogenic shock and intra-aortic balloon counterpulsation. Crit Care Med (2000) 1.38
Lesion-to-lesion relationship of the restenosis process after placement of coronary stents. Catheter Cardiovasc Interv (2000) 1.38
[The value of echocardiography for the assessment of chronic mitral valve insufficiency]. Dtsch Med Wochenschr (1999) 1.38
The optimal management of cardioversion of atrial fibrillation or flutter: still a 'stunning' problem. Eur Heart J (2000) 1.37
Radon therapy for the treatment of rheumatic diseases--review and meta-analysis of controlled clinical trials. Rheumatol Int (2003) 1.32
Endobronchial sonography: feasibility and preliminary results. Thorax (1992) 1.30
Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol (1990) 1.29
Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation (2001) 1.27
[Guidelines for therapy of chronic heart failure]. Z Kardiol (2005) 1.24
Analysis of shape and motion of the mitral annulus in subjects with and without cardiomyopathy by echocardiographic 3-dimensional reconstruction. J Am Soc Echocardiogr (2000) 1.24
Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19). J Cancer Res Clin Oncol (2005) 1.22
Large differences in substitutional pattern and evolutionary rate of 12S ribosomal RNA genes. Mol Biol Evol (1996) 1.19
Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy. Am J Cardiol (1980) 1.18
Transoesophageal cross-sectional echocardiography with a phased array transducer system. Technique and initial clinical results. Br Heart J (1982) 1.18
The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions; results of a randomized trial. Eur Heart J (2001) 1.15
Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia (2011) 1.15
Cysts in left atrial myxomas identified by transesophageal cross-sectional echocardiography. Am J Cardiol (1983) 1.15
Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study. Eur Heart J (2001) 1.15
Transthoracic echocardiography using second harmonic imaging: diagnostic alternative to transesophageal echocardiography for the detection of atrial right to left shunt in patients with cerebral embolic events. J Am Coll Cardiol (1999) 1.13
Transesophageal two-dimensional echocardiography: comparison of ultrasonic and anatomic sections. Am J Cardiol (1984) 1.13
Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol (1994) 1.12
Transesophageal two-dimensional echocardiography in the diagnosis of cor triatriatum in the adult. J Am Coll Cardiol (1983) 1.11
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT). Eur Heart J (1999) 1.10
Functional characteristics of myocardial bridging. A combined angiographic and intracoronary Doppler flow study. Eur Heart J (1997) 1.09
Detection of ostium secundum atrial septal defects by transoesophageal cross-sectional echocardiography. Br Heart J (1983) 1.07
Successful lysis of mobile right heart and pulmonary artery thrombi, diagnosis and monitoring by transoesophageal echocardiography. Eur Heart J (1996) 1.07
Asymptomatic left ventricular malposition of a transvenous pacemaker lead through a sinus venosus defect: follow-up over 17 years. Pacing Clin Electrophysiol (1991) 1.07
Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol (1997) 1.06
[Clinically relevant breath tests in gastroenterological diagnostics--recommendations of the German Society for Neurogastroenterology and Motility as well as the German Society for Digestive and Metabolic Diseases]. Z Gastroenterol (2005) 1.06
A rare but life-threatening complication of ventriculo-atrial shunt. Acta Neurochir (Wien) (2005) 1.02
Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases. Genes Immun (2009) 1.01
Predictive value of markers of myocardial reperfusion in acute myocardial infarction for follow-up left ventricular function. Am J Cardiol (2001) 1.01
Transesophageal 2-D echocardiographic feature of flail mitral leaflet due to ruptured chordae tendineae. Am Heart J (1984) 1.00
Influence of nifedipine on left ventricular dysfunction at rest and during exercise. Eur Heart J (1982) 0.98
Transoesophageal echocardiography in the diagnosis of cor triatriatum; incremental value of colour Doppler. Eur Heart J (1992) 0.98
Transcoronary venous radiofrequency catheter ablation of ventricular tachycardia. J Cardiovasc Electrophysiol (1997) 0.98
A metabolic syndrome of hypertension, hyperinsulinaemia and hypercholesterolaemia in the New Zealand obese mouse. Eur J Clin Invest (2000) 0.97
The role of atrial septal abnormalities in cryptogenic stroke - still questionable? Eur Heart J (2001) 0.97
Planimetry of orifice area in aortic stenosis using multiplane transesophageal echocardiography. J Am Coll Cardiol (1993) 0.97
Creatine kinase release in acute myocardial infarction: correlation with clinical, electrocardiographic, and pathological findings. Br Heart J (1975) 0.97
Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol (1996) 0.97
Tissue tracking allows rapid and accurate visual evaluation of left ventricular function. Eur J Echocardiogr (2001) 0.96
Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br J Cancer (2013) 0.96
Quantitative analysis of the morphology of secundum-type atrial septal defects and their dynamic change using transesophageal three-dimensional echocardiography. Circulation (1997) 0.96
Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol (1998) 0.95
Catheter stimulation of cardiac parasympathetic nerves in humans: a novel approach to the cardiac autonomic nervous system. Circulation (2001) 0.95
Standardized guidelines for the interpretation of dobutamine echocardiography reduce interinstitutional variance in interpretation. Am J Cardiol (1998) 0.95
The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med (2001) 0.94
Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart (2006) 0.93
Mechanisms of acute lumen gain and recurrent restenosis after rotational atherectomy of diffuse in-stent restenosis: a quantitative angiographic and intravascular ultrasound study. J Am Coll Cardiol (1999) 0.93
Alterations of cell-mediated immunity following cardiac operations: clinical implications and open questions. Shock (2001) 0.93
Balance of pro-apoptotic transforming growth factor-beta and anti-apoptotic insulin effects in the control of cell death in the postnatal mouse retina. Eur J Neurosci (2005) 0.93
Thiol-proteindisulfide-oxidoreductase (proteindisulfide isomerase): a new plasma membrane constituent of mature human B lymphocytes. Scand J Immunol (1994) 0.93